Grant Sean's Form 4 filing
Vera Therapeutics, Inc. (VERA) · filed Apr 5, 2024
- Accession no.
- 0001415889-24-010473
- Filed
- Apr 5, 2024
- Trade date
- Apr 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 20 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.69M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Grant SeanCIK 0001872792 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2024 | Class A Common Stock | MOption exerciseAcquired | +99,828 | $14.87 | +$1,484,442.36 | 166,165 | Direct | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −69,831 | $40.05 | −$2,796,731.55 | 96,334 | Direct | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −10,988 | $38.65 | −$424,686.2 | 85,346 | Direct | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −11,648 | $38.13 | −$444,138.24 | 73,698 | Direct | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −7,361 | $39.25 | −$288,919.25 | 66,337 | Direct | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −78 | $38.20 | −$2,979.6 | 257 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −80 | $39.22 | −$3,137.6 | 177 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −177 | $40.06 | −$7,090.62 | 0 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −387 | $38.22 | −$14,791.14 | 1,233 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −366 | $39.19 | −$14,343.54 | 867 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −867 | $40.06 | −$34,732.02 | 0 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −672 | $38.22 | −$25,683.84 | 2,144 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −639 | $39.19 | −$25,042.41 | 1,505 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −1,505 | $40.06 | −$60,290.3 | 0 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −201 | $38.23 | −$7,684.23 | 656 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −203 | $39.20 | −$7,957.6 | 453 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −453 | $40.05 | −$18,142.65 | 0 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −3,112 | $38.22 | −$118,940.64 | 14,909 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −2,944 | $39.19 | −$115,375.36 | 11,965 | Indirect | |
| Apr 3, 2024 | Class A Common Stock | SSaleDisposed | −6,965 | $40.06 | −$279,017.9 | 5,000 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2024 | Class A Common Stock | MOption exerciseDisposed | −99,828 | $0.00 | $0 | 80,172 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.